GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
YOGIN, South Korea, Dec. 18, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the...